Statera Biopharma | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Mar 3, 2023 10:46 ET
Statera Biopharma | DEFR14A: Definitive proxy statement in connection with contested solicitations
Feb 28, 2023 21:06 ET
Statera Biopharma | DEF 14A: Definitive proxy statements
Feb 27, 2023 06:01 ET
Statera Biopharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Feb 15, 2023 09:08 ET
Statera Biopharma | 8-K: Current report
Feb 1, 2023 16:34 ET
Statera Biopharma | 8-A12G: Others
Feb 1, 2023 16:08 ET
Statera Biopharma | 8-K: Current report
Jan 20, 2023 16:53 ET
Statera Biopharma | DEF 14A: Definitive proxy statements
Nov 28, 2022 16:19 ET
Statera Biopharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Nov 18, 2022 08:02 ET
Statera Biopharma | 8-K: Current report
Nov 15, 2022 06:04 ET
Statera Biopharma | 10-Q: Q3 2022 Earnings Report
Nov 14, 2022 17:22 ET
Statera Biopharma | 8-K: Current report
Nov 4, 2022 21:51 ET
Statera Biopharma | D: Filing D
Nov 4, 2022 18:59 ET
Statera Biopharma | 10-Q: Quarterly report
Oct 28, 2022 08:49 ET
Statera Biopharma | 8-K: Current report
Oct 27, 2022 17:00 ET
Statera Biopharma | 8-K: Current report
Oct 24, 2022 06:08 ET
Statera Biopharma | 10-Q: Q1 2022 Earnings Report
Oct 21, 2022 09:00 ET
Statera Biopharma | 8-K: Current report
Oct 17, 2022 17:30 ET
Statera Biopharma | 10-K: FY2021 Annual Report
Oct 5, 2022 18:00 ET
Statera Biopharma | 8-K: Current report
Sep 27, 2022 11:26 ET
No Data
No Data